Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E W Radue

Showing results (51-60 of 72) with videos related to

Pageof 8
Sort By:
European Radiology|February 24, 2001
Preliminary experience with dynamic MR projection angiography in the evaluation of cervicocranial steno-occlusive diseaseS G Wetzel, R Haselhorst, D Bilecen, et al.
Neurology|January 26, 2005
Rate of brain atrophy in relapsing MS decreases during treatment with IFNbeta-1aM Hardmeier, S Wagenpfeil, P Freitag, et al.
European Journal of Neurology|January 26, 2016
Daclizumab high-yield process reduced the evolution of new gadolinium-enhancing lesions to T1 black holes in patients with relapsing-remitting multiple sclerosisE-W Radue, T Sprenger, T Vollmer, et al.
European Journal of Neurology|December 21, 2012
Six-year follow-up of a case series with non-communicating syringomyelia in multiple sclerosisK Weier, Y Naegelin, M Amann, et al.
Neurology|July 13, 2005
Neutralizing antibodies and efficacy of interferon beta-1a: a 4-year controlled studyL Kappos, M Clanet, M Sandberg-Wollheim, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 3, 2013
Five-year results from a phase 2 study of oral fingolimod in relapsing multiple sclerosisG Izquierdo, P O'Connor, X Montalban, et al.
Neurology|November 27, 2002
A randomized, double-blind, dose-comparison study of weekly interferon beta-1a in relapsing MSM Clanet, E W Radue, L Kappos, et al.
Translational Psychiatry|March 25, 2015
Increased functional connectivity in the resting-state basal ganglia network after acute heroin substitutionA Schmidt, N Denier, S Magon, et al.
Current Pharmaceutical Design|August 20, 2009
The effects of antipsychotics on the brain: what have we learnt from structural imaging of schizophrenia?--a systematic reviewR Smieskova, P Fusar-Poli, P Allen, et al.
Lancet (London, England)|August 25, 1999
Predictive value of gadolinium-enhanced magnetic resonance imaging for relapse rate and changes in disability or impairment in multiple sclerosis: a meta-analysis. Gadolinium MRI Meta-analysis GroupL Kappos, D Moeri, E W Radue, et al.
Pageof 8

Showing results (51-60 of 72) with videos related to

Sort By:
Pageof 8
European Radiology|February 24, 2001
Preliminary experience with dynamic MR projection angiography in the evaluation of cervicocranial steno-occlusive diseaseS G Wetzel, R Haselhorst, D Bilecen, et al.
Neurology|January 26, 2005
Rate of brain atrophy in relapsing MS decreases during treatment with IFNbeta-1aM Hardmeier, S Wagenpfeil, P Freitag, et al.
European Journal of Neurology|January 26, 2016
Daclizumab high-yield process reduced the evolution of new gadolinium-enhancing lesions to T1 black holes in patients with relapsing-remitting multiple sclerosisE-W Radue, T Sprenger, T Vollmer, et al.
European Journal of Neurology|December 21, 2012
Six-year follow-up of a case series with non-communicating syringomyelia in multiple sclerosisK Weier, Y Naegelin, M Amann, et al.
Neurology|July 13, 2005
Neutralizing antibodies and efficacy of interferon beta-1a: a 4-year controlled studyL Kappos, M Clanet, M Sandberg-Wollheim, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 3, 2013
Five-year results from a phase 2 study of oral fingolimod in relapsing multiple sclerosisG Izquierdo, P O'Connor, X Montalban, et al.
Neurology|November 27, 2002
A randomized, double-blind, dose-comparison study of weekly interferon beta-1a in relapsing MSM Clanet, E W Radue, L Kappos, et al.
Translational Psychiatry|March 25, 2015
Increased functional connectivity in the resting-state basal ganglia network after acute heroin substitutionA Schmidt, N Denier, S Magon, et al.
Current Pharmaceutical Design|August 20, 2009
The effects of antipsychotics on the brain: what have we learnt from structural imaging of schizophrenia?--a systematic reviewR Smieskova, P Fusar-Poli, P Allen, et al.
Lancet (London, England)|August 25, 1999
Predictive value of gadolinium-enhanced magnetic resonance imaging for relapse rate and changes in disability or impairment in multiple sclerosis: a meta-analysis. Gadolinium MRI Meta-analysis GroupL Kappos, D Moeri, E W Radue, et al.
Pageof 8